Suk Hang Cheng

Title: Suk Hang Cheng: Innovator in Molecular Analyses

Introduction

Suk Hang Cheng is a prominent inventor based in Fanling, China. He has made significant contributions to the field of molecular biology, particularly in the analysis of cell-free DNA during pregnancy. With a total of six patents to his name, Cheng's work has the potential to revolutionize prenatal diagnostics.

Latest Patents

One of Cheng's latest patents focuses on molecular analyses using long cell-free DNA fragments in pregnancy. The methods and systems described involve utilizing these long fragments to analyze biological samples from pregnant subjects. The status of methylated CpG sites and single nucleotide polymorphisms (SNPs) is often used to assess DNA fragments. Typically, a CpG site and a SNP are separated by hundreds or thousands of base pairs, making it improbable to find consecutive sites on most cell-free DNA fragments. However, fragments longer than 600 base pairs may include multiple CpG sites and/or SNPs. This presence allows for more comprehensive analysis compared to shorter fragments. The long cell-free DNA fragments can also help identify the tissue of origin and provide valuable information about the fetus in a pregnant female.

Career Highlights

Cheng has worked with notable institutions, including The Chinese University of Hong Kong and Grail, Inc. His research has been instrumental in advancing the understanding of prenatal diagnostics and molecular biology.

Collaborations

Cheng has collaborated with esteemed colleagues such as Yuk-Ming Dennis Lo and Rossa Wai Kwun Chiu, contributing to the advancement of research in his field.

Conclusion

Suk Hang Cheng's innovative work in molecular analyses has the potential to significantly impact prenatal diagnostics. His contributions to the field are noteworthy and continue to inspire advancements in medical technology.